Polymorphism in processes of crystallization in solution;Polymorphisme dans les procédés de cristallisation en solution

S.T.P. Pharma Pratiques

Volumn 15, Issue 1, 2005, Pages 53-84

  Veesler, S ^a   Puel, F ^b   Fevotte, G ^b  

^a CNRS   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Crystal habit; Crystallization; Morphology; Polymorphism; Process

Indexed keywords

ORGANIC COMPOUND;

CRYSTAL STRUCTURE; CRYSTALLIZATION; DISSOLUTION; DRUG INDUSTRY; KINETICS; MORPHOLOGY; PHASE TRANSITION; QUALITY CONTROL; REVIEW; SCREENING; SOLID;

EID: 18844412141     PISSN: 11571497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Boistelle, R., «Actualités néphrologiques» Crosnier J. Funck Brentano J.L, Bach J.F., Grunfeld J.P Ed Flammarion Médecine Sciences (1985) 159-202
2. Cambridge Crystallographic Data Center: www.ccdc. cam.ac.uk
3. Yu L., Stephenson G.A, Mitchell C.A, Bunnell C.A, Snorek S.V., J. Bowyer J., Borchardt T.B, Stowell J.G., Byrn S.R. «Thermochemistry and Conformational Polymorphism of a Hexamorphic Crystal System», J. Am. Chem Soc. 122, 585-591, 2000
4. Blagden N and Davey RJ, Polymorphs take shape, Chemistry in britain, March 1999, 44-47
5. Otsuka M, Ofusa T and Matsuda Y, Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding, Colloids and Surfaces B: Biointerfaces, 1999, 13
6. Pikal M.J. «Impact of polymorpism on the quality of lyophilized products» in «Polymorphism in pharmaceutical solids», ed G. Brittain Marcel Dekker inc 1999
7. Haleblian JK, J. Pharm. Sci., 1975, 64, 1269.
8. Byrn SR, Solid-state chemistry of drugs. Academic Press New York, 1982
9. Bernstein J and Goldstein E, The Polymorphic Structure of a Squarylium Dye. The Monoclinic (Green) and Triclinic (Violet) Forms of 2,4-bis(2-hydroxy 4-diethylaminophenyl)-1,3-cydobutadienediylium 1,3-diodate, Mol. Cryst. Liq. Cryst., 1988, Vol. 164, 213-229.
10. Walstra P, Food Structure and Behavior, New York: Academic, 1987, 67-85.
11. Giron D. «Thermal analysis and calorimetric methods in the characterisation of polymorphs and solvate» Thermichemica Acta 248 (1995) 1-59
12. Sato K. (1993). «Polymorphic transformations in crystal growth.» J. Phys. D: Appl. Phys. 26: B77-B84.
13. Puel F., Veesler S. Mangin D. «Cristallisation: aspects théoriques» Techniques de l'Ingénieur, J2710, à paraître en 2005
14. Nielsen A.E. Sohnel O. (1971). «Interfacial tensions electrolyte crystal-aqueous solution, from nucleation data.» J. Crystal Growth 11: 233-242.
15. Boistelle, R. Crystal growth from non aqueous solutions. In B Mutaftschiev: Interfacial aspects of phase transformations, D. Reidel, Dordrecht, pp. 531-557, 1982
16. Hartman, P. Crystal Growth: an Introduction. North Holland, Amsterdam, pp.531, 1973.
17. Zettlemoyer AC. Nucleation. M. Dekker Inc., New York, 606 pages, 1969.
18. Abraham, FF. Homogeneous nucleation theory. Academic Press, New York, pp.263, 1974.
19. Toschev, S. Homogeneous nucleation. In P Hartman: Crystal Growth: an introduction, North Holland, Amsterdam, pp. 1-49, 1973.
20. Kaschiev D. «Nucleation: Basic theory with applications», Butterworth-Heinemann, Oxford (2000)
21. Boistelle, R. Abbona, F. Berland, Y et al. Les domaines de nucléation du phosphate ammoniaco magnésien dans les urines stériles, alcalines ou acides. Néphrologie, 5, 217, 1984.
22. Nielsen, A.E, Toft, J.M. Electrolyte crystal growth kinetics. J Crystal Growth, 67, 278, 1984.
23. Bliznakov, G. Kirkova, E Et Nikolaeva, R. A study of the rate controlling stage of the process of crystal growth from solutions. Kristall und Technik, 6, 33, 1977.
24. Rosenberger, F. Fundamentals of Crystal Growth I. Berlin, Springer Verlag, pp. 530, 1979.
25. Ostwald W, Z. Phys. Chem., 1897, 22, 289.
26. [Day, 2001]. Day, M. Pharmaceutical Technology Europe, vol.13, 4, 22-27.
27. Boistelle, R, Rinaudo, C. Phase transitions and epitaxies between hydrated orthorhombic and anhydrous monoclinic uric acid crystals. In GH Nancollas: Biological mineralization, North Holland, Amsterdam, pp. 1-9, 1981.
28. 3. J Crystal Growth, 49, 569, 1980.
29. Kitamura M. (1989). «Polymorphism in the crystallization of 1-glutamic acid.» J. Crystal Growth 96: 541-546.
30. Garcia E., Veesler S., et al. (1999). «Crystallization and dissolution of pharmaceutical compounds an experimental approach.» J. Crystal Growth 198/199: 1360-1364.
31. Garcia E, Hoff C. Veesler S., Dissolution and phase transition of pharmaceuticals compounds» J. Cryst. Growth 237-239 (2002) 2233-2239
32. Ferrari E. S., Davey R. J., Cross W. I., Gillon A. L., Towler C. S. «Crystallization in polymorphic systems: the solution-mediated transformation of β to a glycine.» Crystal Growth & Design (2003)3, 53-60. Sous presse.
33. Cardew P.T., Davey R.J. (1985). «The kinetics of solvent-mediated phase transformation.» Proc. R. Soc. Lond. A 398: 415-428.
34. Chemburkar S.R., Bauer J., Deming K. Spiwek H., Patel K., Morris J., Henry R., Spanton S., Dziki W., Porter W., Quick J., Bauer P., Donaubauer J., Naryanan B.A., Soldani M., Riley D., McFarland K. Dealing with the impact of ritonavir polymorphs on the late stages of drug process development, Organic Process Research and Development, 2000, 4, 413-417
35. Morissette S.L, Soukasene S., Levinson D., Cima M.J., Almarsson O. (2003) «Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization» Proceedings of the National Academy of Science of the United States PNAS 2003 100, 2180-2184 www. pnas.org_cgi_doi_10.1073_pnas.0437744100 (2003)
36. Dunitz JD, Bernstein J, Disappearing polymorphs, Acc. Chem. Res., 1995, 28, 193-200.
37. Bladgen N. Davey R.J. Polymorph selection: challenges for the future? Crystal Growth & Design (2003) 3(6) pp 873-885.
38. Haleblian J and Mc Crone W, Pharmaceutical Applications of Polymorphism, Journal of Pharmaceutical Sciences, August 1969, Vol. 58, No. 8, 911-929.
39. Takigushi H, Yano J, Nakada T, Miyashita S, Komatsu H and Sato K, Control of polymorphic occurrence of behenic acid thin films in physical vapor deposition, J. Crystal Growth, 1999, 205, 575-583.
40. Kashchiev D and Sato K, Kinetics of crystallisation preceded by metastable-phaseformation, J. Chemical Physics, 15 November 1998, Vol. 109, No. 19, 8530-8540.
41. Bartolomei M, Bertocchi P, Cotta Ramusino M and Ciranni Signoretti E, Thermal studies on the polymorphic modifications of (R,S) propanolol hydrochloride, Thermochimica Acta, 1998, 321, 43-52
42. Davey RJ, Richards J, A solvent mediated phase transformation in an aqueous suspension of an azo-disperse dye, Journal of Crystal Growth, 1985, 71, 597-601.
43. Byrn SR, Pfeiffer RR, Stephenson G, Grant DJW and Gleason WB, Solid-State Pharmaceutical Chemistry, Chem. Mater., 1994, 6, 1148-1158.
44. Caira MR, Crystalline Polymorphism of Organic Compounds, Topics in Current Chemistry, 1998, Vol. 198, 163-208.
45. Righini S, Polymorphic Transformation of 2,6-Dihydroxybenzoic Acid (2,6-DHB), Mphil thesis, UMIST January 2000.
46. Sato K and Boistelle R, Occurrence of Stearic Acid Polymorphs from Cyclohexane Solutions, Journal of Colloid and Interface Science, August 1983, Vol. 94, No 2, 593-596.
47. Sato K and Boistelle R, Stability and occurence of polymorphic modifications of Stearic acid in polar and nonpolar solutions, Journal of Crystal Growth, 1984, 66, 441-450.
48. Beckmann W. and Otto W.H., Occurrence, stability, kinetics of crystallization and polymorphic transition of the A,B and C modification of abecarnil Translchem E, Vol 74, Part A, October 1996.
49. Bladgen N., Davey R.J., Rowe R., Roberts R. (1998). «Disappearing polymorphs and the role of reaction by-products: the case of sulphathiazole.» International J. Pharmaceutics 172: 169-177.
50. Bauer J., Spanton S., Henry R., Quick J., Dziki W., Porter W. and Morris J. (2001). «Ritonavir: An Extraordinary Example of Conformational Polymorphism.» Pharmaceutical Research 18(6): 859-866.
51. Davey R. J., Bladgen N., Potts G.D., Docherty R. (1997). «Polymorphism in molecular crystals: stabilization of a metastable form by conformational mimicry.» Journal of American Chemical Society 119: 1767-1772.
52. Staab E., Addadi L., Leiserowitz L., Lahav M. (1990). «Control of polymorphism by tailor-made polymeric crystallization auxiliaries. Preferential precipitation of a metastable polar form for second harmonic generation.» Advanced Materials 2(1): 40-43.
53. Gu C., Chatterjee K., Young Jr. V. and Grant D.J.W. (2002). «Stabilization of a metastable polymorph of sulfamerazine by structurally related additives.» Journal of Crystal Growth 235: 471-481.
54. Beckmann W, Nucleation phenomena during the crystallisation and precipitation of Abecarnil, Journal of Crystal Growth, 1999, 198/199, 1307-1314
55. Edwards, A D; Shekunov, B Y; Kordikowski, A; Forbes, R T; York, P, Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS), Journal of Pharmaceutical Sciences, Volume 90, Issue 8, August 2001, Pages 1115-1124
56. Baltes D, Mangin D., Monnier O., Hoff C., Klein J.P. « Cristallisation en fluide supercritique: influence des paramètres opératoires et contrôle de la cristallinité» Actes de conférences, Cristal 3, 24 et 25 Novembre 2004, EMSE St Etienne, p 90-96, 2004
57. Davey RJ, Cardew PT, McEwan D, Sadler DE, Rate controlling processes in solvent-mediated phase transformations, Journal of Crystal Growth, 1986, 79, 648-653.
58. Beckmann W. Seeding the desired polymorph: background, possibilities, limitations and case studies, Organic Process Research and Development, 2000, 4, 372-383
59. Starbuck C., Spartalis A., Wai L, Wang J., Fernandez P., Lindemann C.M., Zhou G.X., Ge Z. «Process optimization of complex Pharmaceutical Polymorphic system via In Situ Raman Spectroscopy» Crystal Growth & Design (2002) Vol 2 No 6 515-522
60. Amathieu L. et Boistelle R., Crystallization kinetics of gypsum from dense suspension of hemihydrate in water J. Cryst. Growth 88 (1988) 183-192
61. Lewiner F., Klein J-P., Puel F. and Fevotte G. On-line ATR FTIR measurement of supersaturation during solution crystallization processes. Calibration and applications on three solute/solvent systems, Chem. Eng. Sci. 2001, 56, 6 2059-2084
62. Davey R.J., Blagden N., Righini S., Alison H. and Ferrari E.S. «Nucleation control in solution mediated phase transformations: the case of 2,6-dihydroxybenzoic acid» J. Phys. Chem, B2002, 106, 1954-1959.
63. Veesler, S., L. Lafferrere, E. Garcia and C. Hoff (2003). «Phase transitions in supersaturated drug solution.» Organic Process Research and development 7(6): 983-989.
64. Ferrari E.S., Davey R.J., Cross W.I., Gillon A.L., Towler C.S. Crystallization in polymorphism systems: the solution mediated transformation of β to α glycine. Crystal growth & Design (2003), 3 (1) pp 53-60.
65. Caillet A., Puel F., Fevotte G. «Suivi de la transition de phase de l'acide citrique par spectroscopie Raman in situ» Actes de conférences, Cristal 3, 24 et 25 Novembre 2004, EMSE St Etienne, p 128-133, 2004
66. Févotte G., Calas J.; Puel F., Hoff C. «Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes» Int. J. of Pharmaceutics, 273 159-169 (2004)
67. Veesler, S., N. Ferté, M. S. Costes, M. Czjzek and J. P. Astier (2004). «Temperature and pH effect on the polymorphism of Aprotinin (BPTI) in sodium bromide solutions.» Crystal Growth & Design 4(6): 1137-1147.
68. Nyvlt, J., Sohnel O., Matuchova M., Broul M. The Kinetics of industrial crystallization. Elsevier, Amsterdam, 1985.
69. Mullin J.W. «Crystallization» 4th edition, Butterworth-Heinemann, Oxford, 2001.
70. Virtanen, J. In Industrial Crystallization 84, ed. Jancic et long, Elsevier, 1984.
71. Miller S.M., Rawlings J.B. AIChE J., vol. 40, 8, p. 1312-1327, 1994.
72. Eek R.A., Both J., Van der Hof P.M.J. Selected Topics in Identification, Modelling and Control, 7, Delft University Press. December 1994.
73. Qiu Y., Rasmusson A.C. AIChE J., 40, 5, p. 799-812, 1994.
74. de Wolf S., Jager J., Bosgra O.H., Kramer H.J.M. 11th Symp. on Industrial Cryst. A. Mersmann ed., Garmisch Partenkirschen, 1990.
75. Allen T., Particle size measurement, Fourth edition. Chapman and Hall, 1991.
76. Rawlings J.B., Miller S.M., Witkowski W.R. Ind. Eng. Chem. Res., 32, p.1275-1296, 1993.
77. Matthews H.B., Rawlings J.B. AIChE J., 44, n°5, p.1119-27 1998.
78. Heffels S.K., De Jong E.J. AIChE Symp. Series, 87 (284), p.770-181, 1991.
79. Monnier O., Klein J.P., Hoff C., Ratsimba B. Part. Part. Syst. & Caract. 13, p. 10-17, 1995.
80. Monnier O., Févotte G.; Hoff C., Klein J.P. Chem. Engng. Sci., 52(7) p.1125-1139, 1997.
81. Farrell R.J., Y.C. Tsai, AIChE J., vol. 41, n°10, p.2318-2321, 1995.
82. Tähti T., Louhi-Kultanen M., Palosaari S. 14th International Symp. Industrial Crystallization, IChemE Publisher, Cambridge, UK, 12-16 sept. 1999,
83. Monnier O. «The use of FBRM to improve an Isomer Separation process» Lasentec Users Forum, Barcelona, Spain 2001.
84. Monnier O. «Pseudo polymorph transition: the use of FBRM and PVM» Lasentec Users Forum, Barcelona, Spain 2001.
85. Lafferrere, L., C. Hoff and S. Veesler (2004). «In situ monitoring of the impact of liquid-liquid phase separation on drug crystallization by seeding.» Crystal Growth & Design 4(6): 1775-1180.
86. Day, M. Pharmaceutical Technology Europe, vol.13, 4, 22-27
87. Markovich, R.J., Anderson Evans, C., Coscolluela, C.B., Zibas, S.A., Rosen, J., 1997 J. Pharm. Biomed. Anal., 16, 661-673.
88. Buckton, G., Yonemochi, J., Hammond, A. Moffat, A., Int. J. Pharm (1999)168, 231-241.
89. Salari, A., Young, R.E., 1988. Int. J. Pharm., 163, 157-156.
90. Skrdla, P.J., Antonucci, V., Crocker, L.S., Wenslow, R.M., Wright, L., Zhou, C., 2001. J. Pharm. Biomed. Anal., 25, 731-739.
91. Vaccari, G., Tamburini, S.T., Tosi, S., Sgualdino, G., Bernardi, T. Chemical Eng. Trans. (AIDC), A. Chianese Ed., 2002, Vol. 7, 1143-1148.
92. Wang, F., Wachter, J.A., Antosz, F.J., Berglund, K.A. Org. Proc. Res. Dev., (2000)4, 391-395
93. Agarwal P., Berglund K.A. «In Situ Monitoring of Calcium Carbonate Polymorphs during Batch Crystallization in the Presence of Polymeric Additives Using Raman Spectroscopy» Crystal Growth & Design 3, 6, 941-946 2004
94. Ono T., ter Horst J.H., Jansens P.J. «Quantitative measurement of the polymorphic transformation of L-Glutamic acid using In Situ Raman spectroscopy» Cryst. Growth & Design V4, N3, 465-469 (2004)
95. Lauret P. Nouvelles approches de modélisation de la cristallisation en sucrerie de cannes. Thèse Université de la Réunion, 1998.
96. Leci C.L., Mullin J.W. Chemistry & Industry, p.1517, 1968.
97. Sikdar S.K., Randolph A.D. AIChE J., 22, 1, p.110-117, 1976.
98. Helt J.E., Larson M.A. AIChE J., vol.23, 6, p.822-830, 1977.
99. Mullin J.W., Leci C.L. AIChE Symp. S., n°121, 68, p.8-20, 1972.
100. Kohl, M. «Etude de l'ensemencement d'un cristallisoirde chimie fine» PhD dissertation, UCB Lyon I, n° 72-2000, 2000
101. Hlozny L.; Sato A. & Kubota, N. J. of Chem. Engng. of Japan, 25, 5, p.604-606, 1992.
102. Nyvlt, J., Karel M. Collect. Czech. Chem. Commun., 58, p.1839-1847, 1993.
103. Franck R., David R., Villermaux J. et Klein J.P. Chem. Engng. Sci., vol.43, n°1, p.69-77, 1988.
104. David R., Villermaux J., Marchal P. et Klein J.P. Chem. Engng. Sci., vol.46, n°4, p.1129-1136, 1991
105. Seyssiecq I., Veesler S., Boistelle R., (1996). «Anon-immersed induction conductivity system for controlling supersaturation in corrosive media: the case of gibbsite crystals agglomeration in Bayer liquors.» J. Crystal Growth 5163: 124-125.
106. Garside J., Mullin J.W. Chemistry & Industry, p.2007-2008, 1966.
107. Riebel U., Kofler V., Löffler F. In Industrial crystallization '90, ed. Mersmann A; p.595-599, 1990.
108. Riebel U., Kofler V., Löffler F. In Industrial crystallization '90, ed. Mersmann A., p.595-599, 1990.
109. Jager J., Kramer H., Scarlett B., de Jong E., de Wolf S. AIChE J., vol.37, n°2, p.182-192, 1991.
110. Jager, J., Kramer H.J., de Jong E.J., de Wolf S., Bosgra O.H., Boxman A., Merkus H.G., Scarlett B.S. (1992). Powder Technol., 69, p.11-20, 1992.
111. Riesen R. Chem. Plants and processing, July, p.26-29, 1992.
112. Févotte G., Klein J.P. The Chem. Engng. J., 59, p. 143-152, 1995.
113. Févotte G., Klein J.P. Trans. Ichem. E., vol.74, A7, p.791-796, 1996.
114. Févotte G., Klein J.P. Can. J. Chem. Engng., 74, 3, p.372-384, 1996.
115. Févotte G., Klein J.P. Chem. Eng. Sci, vol.49, 9, p.1323-36, 1994.
116. Morel S. Thèse Université Claude Bernard Lyon 1, 1998.
117. Doyle WM. Process Control and Quality, 2, p.11-41, 1992.
118. Dunuwila D. An investigation of the feasibility of using in situ ATR FTIR spectroscopy in the measurement of crystallization phenomena for research and development of batch crystallization processes. Dissertation, Michigan State University, Dept. of Chem. Engng., 1996.
119. Dunuwila D., Berglund K.A. J. Crystal Growth, 179, p.185-193, 1997
120. M.S. Uusi-Penttilä M.S., Berglund, K.A. Proceedings of 4th Int. Worshop on Crystal Growth, Bremen, 1997.